The COX-active enantiomer of flurbiprofen
Related Products
Active Metabolite(s)
216914'-hydroxy Flurbiprofen
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

(S)-Flurbiprofen

Item No. 10004207

Technical Information
Formal Name
(S)-(+)-2-fluoro-α-methyl-4-biphenylacetic acid
CAS Number
51543-39-6
Molecular Formula
C15H13FO2
Formula Weight
Purity
≥99%
Formulation
A crystalline solid
DMF: 25 mg/mlDMSO: 10 mg/mlEthanol: 25 mg/mlPBS (pH 7.2): 0.9 mg/ml
λmax
247 nm
SMILES
FC1=CC([C@@H](C(O)=O)C)=CC=C1C2=CC=CC=C2
InChi Code
InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)
InChi Key
SYTBZMRGLBWNTM-UHFFFAOYSA-N
Shipping & Storage Information
Storage
Room temperature
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    (S)-Flurbiprofen is the COX-active enantiomer of the non-selective COX inhibitor flurbiprofen (Item No. 70250) with IC50 values of 0.48 and 0.47 µM for COX-1 and COX-2, respectively, in guinea pig whole blood.1 It inhibits the release of 6-keto prostaglandin F (6-keto-PGF; Item No. 15210) and thromboxane B2 (TXB2; Item No. 19030) from rat whole blood, gastric mucosa, lung, and jejunal tissue ex vivo in a dose-dependent manner.2 (S)-Flurbiprofen (1 nM) inhibits basal and bradykinin-, serotonin-, and histamine-stimulated prostaglandin E2 (PGE2) release from isolated skin flaps of rat lower hind paws.3 It also inhibits release of the neuroinflammatory marker calcitonin gene-related peptide (CGRP; Item Nos. 24405 | 24725 | 24728) when used at a concentration of 1 μM. In vivo, (S)-flurbiprofen reduces the number of flinches per minute in the formalin test in rats, indicating antinociceptive activity.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Carabaza, A., Cabre, F., Rotllan, E., et alStereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugs. J. Clin. Pharmacol. 36, 505-512 (1996).

    2. Peskar, B.M., Kluge, S., Peskar, B.A., et alEffects of pure enantiomers of flurbiprofen in comparison to racemic flurbiprofen on eicosanoid release from various rat organs ex vivo. Prostaglandins 42(6), 515-531 (1991).

    3. Averbeck, B., Peisler, M., Izydorczyk, I., et alInflammatory mediators do not stimulate CGRP release if prostaglandin synthesis is blocked by S(+)-flurbiprofen in isolated rat skin. Inflamm. Res. 52(12), 519-523 (2003).

    4. Malmberg, A.B., and Yaksh, T.L. Antinociception produced by spinal delivery of the S and R enantiomers of flurbiprofen in the formalin test. Eur. J. Pharmacol. 256(2), 205-209 (1994).